Search

everythinglearnresearchcommunity

for

Search:↓

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Yellow and orange colors are important for diagnosing certain skin conditions.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

A woman's diabetes improved after removing ovarian tumors that caused high testosterone levels.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

A child with low platelets and anemia was later found to have lupus.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Hair loss in a child was an early sign of Crohn's disease.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

More research is needed to find the best long-term treatments for Alopecia Areata.

Early diagnosis and treatment of achalasia and hyperthyroidism improve patient outcomes.

Henna has many medicinal uses but needs more research to confirm its benefits.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.